title: [Airway inflammation in cystic fibrosis].
abstract: Airway inflammation is now recognized as a major factor in the pathogenesis of lung disease in cystic fibrosis. Inflammation is early, sustained and severe. Several anti-inflammatory therapeutic approaches have been developed, but are controversial.
authors.affiliation: Pédiatrie I Centre hospitalier universitaire de Nancy Hôpital d'Enfants 54511 Vandoeuvre-lès-Nancy. j.derelle@chu-nancy.fr
authors.forename: Jocelyne
authors.initials: J
authors.lastname: Derelle
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D003550:Cystic Fibrosis / Q000188:drug therapy / Q000503:physiopathology*; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use; D007249:Inflammation / Q000188:drug therapy / Q000503:physiopathology; D012140:Respiratory Tract Diseases / Q000188:drug therapy / Q000503:physiopathology*
chemical_list: D000305:Adrenal Cortex Hormones; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007052:Ibuprofen